Lev20 - would like to believe that they will follow through on the buy-back, but at the moment their actions speak very loudly that they are not really trying.
As you have pointed out numerous times, they no longer have a debt issue, the business is performing solidly and they are generating strong cash, so the notion that you hang back on the buyback to save maybe $500k of additional (tax deductible) interest cost in the half year does not make sense.
I am wondering if this has now just become a strategic plaything for Seven Group (SVW). Potentially the real strategy here is to pay down the debt to almost nothing, keep the share price deliberately low (noting the, yet again, underwhelming market response to this announcement) and then have Seven Group swoop in and buy out the remaining shareholders for cents in the $ so SVW can consolidate and utilise the cashflows to further other corporate ambitions.
- Forums
- ASX - By Stock
- SWM
- Ann: Appendix 4D & Half Year Financial Report
SWM
seven west media limited
Add to My Watchlist
3.33%
!
15.5¢

Ann: Appendix 4D & Half Year Financial Report, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $238.5M |
Open | High | Low | Value | Volume |
14.5¢ | 15.5¢ | 14.5¢ | $141.7K | 946.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80801 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 1047806 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80801 | 0.150 |
6 | 1219305 | 0.145 |
15 | 1021259 | 0.140 |
10 | 190360 | 0.135 |
10 | 343803 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 1047806 | 20 |
0.160 | 136037 | 7 |
0.165 | 638470 | 7 |
0.170 | 179097 | 11 |
0.175 | 496403 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SWM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online